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Infection with Trypanosoma cruzi is a major risk in Latin America, and dogs are believed to be good models for evaluating
Chagas disease. Here, we evaluated the clinical and immunopathological alterations developed by mongrel dogs experimentally
infected with diﬀerent infective doses (2,000, 20,000, and 200,000 metacyclic trypomastigotes of Sylvio X10/4 strainkg−1 via
intraperitoneal). Clinical and electrocardiographic parameters, as well as antibody production and pathologic lesions were
evaluated. All three doses of this strain of T. cruzi induced a similar pattern of infection characterized by cardiac arrhythmias
and severe and diﬀuse myocarditis. Speciﬁc anti-T. cruzi IgG indicated seroconversion by day 14 after infection, and IgG levels
increased during the period of evaluation. Mortality was observed only in dogs infected with the medium or high parasite doses,
but not in the group infected with a low dose of 2,000 parasiteskg
−1. Infection with a low dose of parasites provides an excellent
nonlethal model to evaluate the immunopathology of the acute disease in dogs infected with the Sylvio X10/4 strain of T. cruzi.
1.Introduction
Chagas disease is a major public health threat in Latin
America, and dogs are an important domestic reservoir for
infection in humans [1]. In Argentina, the presence of dogs
in dwellings increases the risk for human infection about 3–5
times [2].
Dogs have also been used as a model for evaluating the
process of disease development following Trypanosoma cruzi
infection [1, 3, 4] .S e v e r a ls t u d i e sh a v er e p o r t e dt h eu s eo f
diﬀerent strains and doses to evaluate the infection, which
makes diﬃcult to correlate and compare the results between
them. Strains such as Berenice 78 [5, 6], SC-1 [7]o rTc-O [8]
have been used, with doses ranging from one thousand up
to 5 million trypomastigotes per kilogram of body weight.
It has been demonstrated that diﬀerent strains, routes of
inoculation and animal species developed diﬀerent degrees
of lesion and immunological response and infection aﬀected
a variety of organs [9].
Indeed, T. cruzi parasites have variable tropisms to
diﬀerent organs, which has been attributed to the strain,
number of parasites, the origin of trypomastigotes, the route
of infection, among others [10, 11]. Other studies have
compared blood and metacyclic trypomastigotes, and the
latter were found to be more pathogenic since they produced
a more severe form of disease [6].2 The Scientiﬁc World Journal
In order to evaluate the eﬀect of infection by diﬀerent
parasite doses on the immunopathology of T. cruzi infection
in dogs, we evaluated here three diﬀerent doses of metacyclic
trypomastigotes of the Sylvio X10/4 strain, considered a
pathogenic strain [9], administered via intraperitoneal, to
determine the best challenge model to further study the
immunopathology of T. cruzi in this species.
2.MaterialsandMethods
2.1. Dogs. Eleven clinically healthy mongrel dogs ranging
from 4 to 6 months of age, without clinical and electrocar-
diographic (ECG) alterations seronegative for T. cruzi IgG
by ELISA, were used. They were dewormed, and vaccinated
twice against canine distemper virus, canine parvovirus,
parainﬂuenza, leptospira, and adenovirus type 2, and fed
with a balanced commercial food. The dogs were numbered
and handled as described by the oﬃcial protocols of NOM-
062-ZOO-1999. All procedures were carried out in compli-
ance with the Ethical committee for animal welfare of the
Center of Advanced Studies on Animal Health of the Faculty
of Veterinary Medicine of the Autonomous University of
Mexico State.
2.2. Parasites and Inoculums. Sylvio X10/4 T. cruzi strain,
kindly donated by Dr Nisha Garg (University of Texas
Medical Branch, Galveston), was maintained by serial passes
in NIH 3T3 cells in DMEM medium with 10% fetal bovine
serum (Hyclone, USA), pH 6.8, 5% CO2 at 37◦C[ 12]. The
dogs (D) were randomly assigned into one of three groups
to be infected with 200,000 (high dose) (D1–D3), 20,000
(medium dose) (D4–D7) or 2,000 (low dose) (D8–D11)-live
metacyclic trypomastigotes kg−1.
2.3. Clinical Evaluation. After infection, dogs were evaluated
clinically for signs of disease such as fever, depression, and
anorexia on a daily basis. Hemograms and manual diﬀer-
ential counts were performed every two weeks using an
AcT Coulter programmed for veterinary species according to
equipment instructions. Body weight was measured weekly.
Mortality was calculated for each group.
2.4. Electrocardiography. Electrocardiographic (ECG) re-
cordings were performed at a 50mm/s and 1mV/cm sensi-
tivity and bipolar and unipolar leads were recorded, with a
Cardiofax, NIHON-KOHDEN [13], every two weeks after
infection (PI) [14].
2.5. Serology. Blood samples were obtained by venipuncture
of cephalic vein every two weeks, and total IgG was deter-
mined using MicroELISA (Laboratorio Lemos SRL, Buenos
Aires Argentina), following the manufacturer’s indications,
except that a horse-radish-peroxidase- (HRP-) labeled goat
anti-dog IgG (Bethyl Laboratories) was used at 1:7500 [15].
Dogs serum was used at a 1:100 dilution and the cut-oﬀ
value (OD 450nm + 2 SD) was set using sera from 30
seronegative dogs.
2.6. Parasitemia. Five microliters of EDTA venous blood
were collected every other day starting from day seven until
day 45, and parasites were counted [9]. Brieﬂy, 5μLo f
blood was directly placed between a slide and a cover slide
18 × 18mm and parasites were counted; then results were
multiplied by 200 to obtain the number of trypomastigotes
per milliliter.
2.7. Pathology and Histopathology. At day 45 after infection,
the dogs were euthanized by barbiturates overdose. During
necropsy hearts were removed and weighted. Heart weight
(g)tobody weight(kg)ratiowascalculated[1],todetermine
cardiomegaly and diﬀerences among groups. Myocardium
sections of 0.5cm3 from each wall (right and left auricle and
ventricles and interventricular wall) were cut and embedded
in paraﬃn; then, 5-6 μm thick sections cuts were made from
each wall and stained with hematoxylin and eosin to evaluate
myocarditis in each dog. Ten randomly selectedﬁelds at 400x
were evaluated for inﬂammation using scores 0: when no
inﬂammation was demonstrated; 1: when 30% or less of a
ﬁeld at 400x was inﬁltrated; 2: when 31–60% was aﬀected,
and 3: when more than 65% of a ﬁeld was occupied by
inﬂammatory cells; and diﬀerences between cardiac walls
and groups were evaluated [14]. Amastigote pseudocysts
were counted in 50 randomly selected ﬁelds.
2.8. Statistical Analyses. ECG alterations, mortality, cardiac
inﬂammation, and hematological variables were analyzed
with nonparametric statistics (Wilcoxon, Kruskall-Wallis
and Dunn’s post hoc test) due to their nonnormal distri-
bution and categorical value for some results. All statistical
analyses were performed using Prism 4.0 (Graph Pad, CA,
USA).
3. Results
3.1. Clinical Observations
3.1.1. Clinical Evaluation. All animals gained weight con-
tinuously until the end of the experiment, and no weight
diﬀerences were observed among groups. No clinical signs
of disease or cardiopathy were displayed by dogs during the
ﬁrst 3 weeks of infection; though a dog from the medium
dose group died by day 25 after infection and a dog from the
high dose group died by day 36, both from cardiomyopathy
asshownbynecropsyandhistopathology.Mortalitywasthus
observed in 1/3 (33%) animals infected with a high parasite
dose, 1/4 (25%) from the group infected with a medium
parasite dose, and 0/4 (0%) in the group infected with a low
parasite dose.
3.1.2. Hematologic Findings. Dogs from all groups main-
tained their hematocrit within the reference interval (0.37–
0.54L/L),butdevelopedeosinophilia(>1.3 ×109/L)byweek
1 after infection, which lasted until the third week, though
no statistical diﬀerences were found between groups (P>
0.05). Lymphocyte counts were signiﬁcantly higher on day
14 after infection in the dogs of the high-compared to theThe Scientiﬁc World Journal 3
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Figure 1: Total IgG levels along the evaluation period. Mean and
S.D. of OD450nm for groups infected with high (200,000 MT),
medium(20,000MT)andlow(2,000MT)parasitedoses,showinga
constant increase in antibody levels in dogs on days 0, 14, 28 and 42
post infection. No statistical diﬀerences were found between groups
(P>0.05).
low dose group (P<0.01), but no statistical diﬀerences were
foundbetweenthesegroupsandthemediumdosegroup.No
diﬀerences were found among groups in lymphocyte counts
in samples collected on any other day (days 0, 28, and 42).
3.1.3.Electrocardiography. Dogsfromeverygroupdeveloped
electrocardiographic alterations such as right bundle branch
block (RBBb) (D2 day 14, D8 day 42), low sensitivity of QRS
complex (D1 day 28, D5 day 28), and Atrioventricular block
(D10 and D11 at day 28), and D2 also developed Ventricular
tachycardia considered a life-threatening arrhythmia if not
treated (Table 1).
3.2. Serology. Following infection, all dogs became seropos-
itive by the second week after infection by ELISA IgG
test, except one dog from the medium dose group, which
seroconvertedatweek4.Antibodylevelsincreasedconstantly
during the follow-up until the end of the experiment, but no
statistical diﬀerence was observed between groups (P>0.05,
Figure 1).
3.3. Parasitology. All dogs developed a low parasitemia (Fig-
ure 2), except one dog from the high parasite dose group,
which displayed a high peak of parasitemia (47,000 blood
trypomastigotes mL−1) on day 23. Mean prepatent period
lasted 15, 17, and 21 days for dogs infected with a high,
medium, and low parasite dose, respectively. The peak of
parasitemia was found on days 23, 29, and 25, and lasted for
13, 11, and 21 days for these groups, respectively. Signiﬁcant
diﬀerences were not found for the prepatent period, the
patentperiod,norforthepeakofparasitemiaduetothelarge
variability among individual dogs (Figure 2).
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Figure 2: Parasitemia. Mean parasitemia at diﬀerent days postin-
fection, showing day of prepatent period (PPP), maximum peak
of parasitemia (MP), showing a very erratic pattern alternating
negative with positive parasitemia readings. All dogs showed par-
asitemia but no diﬀerences were found among groups (P>0.05).
Same symbols as Figure 1.
Amastigote nests were present in cardiac tissue of all
dogs, except D6, and were found more frequently in right
ventricular tissue.
3.4. Pathology. At necropsy, all animals displayed slight right
ventricle dilation and infarcted areas distributed all over the
cardiac tissue. Heart:body weight ratio (Cardiac index) was
not signiﬁcantly diﬀerent among groups. Microscopically,
pseudocysts were found in all dogs from the high-dose
group and in one dog from the medium-dose group. No
diﬀerenceswerefoundamongauricularandventricularwalls
or septum tissue in the dogs from the low-parasite-dose
group. However, a larger inﬂammation score was found in
auricles compared to ventricles for dogs infected with a
medium dose (P = 0.027, Figure 3)a n dw i t hah i g hd o s e ,
respectively (P = 0.0032, Figure 4).
Diﬀerent degrees of lymphoplasmacytic inﬂammation
were found in the myocardium of dogs of each diﬀerent
group (Figure 5).
4. Discussion
Although several studies have been performed to test diﬀer-
ent protocols of experimental infection with infective forms
of T. cruzi, there is a lack of standardization on the route,
stage or number of parasites used. Some authors report the
use of blood trypomastigotes, which are easier to obtain
by serial passes in mice [14], while others report the use
of metacyclic trypomastigotes [1, 3, 6], which are more
appropriate because this is the form through which natural
infection occurs. Still, other authors have tested diﬀerences
in infection using diﬀerent routes of inoculation than the4 The Scientiﬁc World Journal
Table 1: Electrocardiography follow-up during evaluation period.
Day 0 14 28 42
Group of high dose (200,000 MT)
D1 Normal Normal Low sensitivity QRS complex Normal
D2 Normal RBBB Ventricular tachycardia +
D3 Normal Normal Normal Normal
Group of medium dose (20,000 MT)
D4 Normal Normal Normal Normal
D5 Normal Normal Low sensitivity QRS complex +
D6 Normal Normal Normal Normal
D7 Normal Normal Normal Normal
Group of low dose (2,000 MT)
D8 Normal Normal Normal RBBB
D9 Normal Normal Normal Normal
D10 Normal Normal AVB I AVB I
D11 Normal Normal AVB I AVB I
Development of EKG alterations in the dogs of diﬀerent groups. Two dogs of low-dose-developed EKG alterations but these were mild and not life threatening
in contrast to those developed by dogs of group high-dose and medium-dose groups which were fatal. AVB I: Atrioventricular block grade 1; RBBB: right
bundle branch block BRD; + dog dead.
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Figure 3:Auriculartissuepresentssigniﬁcantlymoreinﬂammation
than ventricular (P = 0.0027). Mean + SEM is shown.
intraperitoneal route. The clinical, hematological, parasito-
logical, immunological and pathological variables are not
systematically analyzed in the diﬀerent studies, which makes
it more diﬃcult to compare their results. Standardizing the
model might improve this comparison.
In the present study dogs were infected with one of three
diﬀerent doses of parasites (200,000, 20,000, or 2,000 meta-
cyclic trypomastigotes kg−1). During the ﬁrst 3 weeks after
infection, no clinical signs of disease such as fever, anorexia,
pain or diarrhea were found during clinical inspection. The
absence of signs has been previously reported when animals
were infected with diﬀerent stage forms of Trypanosoma
cruzi, it has been observed in natural infections possibly
because the infection may be well controlled in some
animals,thoughothersmayshowseverecardiacinsuﬃciency
due to lethal myocarditis [1, 14]. These ﬁndings are in
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Figure 4: Auricular tissue also presents signiﬁcantly more inﬂam-
mation than ventricular at this dose (P = 0.0032) and Mean + SEM
is shown.
agreement with the clinical diﬃculty to detect the acute
phase of the disease in naturally occurring infection during
a routine clinical inspection, particularly if we consider that
natural infections are likely to occur with an even lower
number of parasites. In the present study, despite the absence
of such clinical signs, one dog infected with a medium
dose and one infected with a high dose died suddenly, on
days 25 and 36 after infection, respectively. Both animals
died from cardiomyopathy as was demonstrated by necropsy
and histopathology and both animals presented abnormal
electrocardiographic readings on days 14 or 28. Such
abnormalities included severe arrhythmias (RBBb and VT).
Surprisingly, dogs with the lowest parasite dose displayed
more arrhythmias (RBBb, AVb I, and AVb I) than those
from the groups with higher infection doses. These forms
of arrhythmias have been reported during natural infectionThe Scientiﬁc World Journal 5
(a) (b) (c)
Figure 5: (a) Slight myocarditis in ventricular wall of dog 9 of the low dose group. (b) Lymphoplasmacytic myocarditis in ventricular wall of
dog 2 of the high dose group. (c) Ventricular wall of dog 4 of medium dose group. Even a dose as low as 2000 trypomastigotes per kilogram
of T. cruzi strain Sylvio 10x can produce evident lesions in myocardium of dogs.
in previous studies [6, 8, 16]. These ﬁndings show that ECG
recordings are a good parameter to evaluate the progress of
disease even at low doses of inoculum. Eosinophilia was the
mostfrequentﬁndinginhemograms,whichsupporttheidea
that eosinophilia might be a nonspeciﬁc hallmark for the
acute phase of T. cruzi infection [13]. Higher lymphocytosis
was observed at day 14 after infection in dogs infected
with a high parasite dose. Hematological alterations such as
eosinophilia,lymphocytosis,andanemiawereobservedinall
dogs of our study, conﬁrming the eﬀectiveness of infection.
Anti-T. cruzi IgG antibody levels increased continuously
during the experimental period, thus, this parameter may be
a good indicator for the development of the immunologic
response that can be used to monitor infection development.
Metacyclic trypomastigotes have been shown to promote
a higher production of IgG antibodies than blood trypo-
mastigotes [6]. Total IgG serum levels were not aﬀected
by the number of parasites inoculated, however, as no
diﬀerences could be observed on days 14, 28, and 45 post-
infection. This may be due to an eﬀective activation of B
cells that produce high levels of IgG independently of the
number of parasites inoculated. Infection was conﬁrmed
as parasitemia was observed in all dogs; however, levels
of parasitemia were erratic, alternating negative to high
counts of blood trypomastigotes. This variability led to large
standard deviations, and therefore no statistical diﬀerences
could be found among treatments. This ﬁnding supports
the idea that parasitemia is not a very reliable diagnostic
parameter used as a single diagnostic test if a single day is
evaluated during the acute phase of the disease, and could be
explained based on individual factors such as immunity and
genetics, as it has been proposed in murine models [4]. The
infection with the lower parasite dose resulted in a delayed
peak of parasitemia (almost a week later) compared with the
high-dose group.
Amastigote nests were present in cardiac tissue of all
dogs except of dog no. 6, and the lowest infectious dose was
able to produce amastigote nests. The right ventricle was
the more frequent location for amastigote nests and might
be the tissue of election to evaluate parasitic load; therefore
quantitative real-time PCR from heart tissue would be an
adequate test to compare parasitic load in this organ, in
experimentally infected animals. No diﬀerences were found
among groups on heart:body weight ratio (cardiac index),
likely because cardiomegaly requires a longer time period
to develop, as suggested previously [13]. While evaluating
the intensity of inﬂammation of myocardium, it was found
t h a ta u r i c l e sw e r em o r es e v e r e l ya ﬀected than ventricles in
dogs from the high- and medium-dose but not in dogs
from the low-dose group. In addition, the auricle within the
same dog was systematically the most aﬀected wall with the
highest inﬂammation score. These ﬁndings are in contrast
with previous observations [14], in which the right ventricle
was the most aﬀected using a local strain of T. cruzi from
Yucat´ an, M´ exico. It is interesting to note that, even though
the auricle displayed the most severe inﬂammatory reaction,
amastigotes were most frequently found in the wall of the
right ventricle. These ﬁndings may indicate that the primary
invasion could have occurred in auricular tissue, followed
by a severe inﬂammatory response that had been working
toward elimination of parasites earlier than other cardiac
tissue areas, which could explain why auricles had lower
numbers of amastigote nests compared with ventricular
tissue, which could have been infected at a later time with
the consequent delayed inﬂammatory response.
5. Conclusions
Ourdogmodelandtheinfectivedoseof2,000metacyclictry-
pomastigotes kg-1 of the Sylvio X10 strain of Trypanosoma
cruzi reproduces the main clinical and pathological features
without being lethal during the course of the ﬁrst 45 days
(acute phase) in dogs, as conﬁrmed by the presence of
parasites, cardiac arrhythmias, and myocarditis after a short
follow-up period. Such standardization of an experimental
challenge capable of inducing the disease is considered
essential when evaluating drugs or vaccines. Serological,
clinical, and standard histopathological methods used in
the present study were able to follow-up infection at all
doses, although parasitemia was highly variable. ELISA is
widely used for the diagnosis of T. cruzi infection because
it is sensitive with good speciﬁcity. In the present study this6 The Scientiﬁc World Journal
diagnostic tests determined infection in dogs very sensitively
at any inoculation dose. This model provides the basis for
future studies concerning immunity and pathology and may
be relevant to study therapeutic agents as well as vaccines.
Authors’ Contributions
All authors contributed equally to this work. I. A. Quijano-
Hern´ andez, J. V. Cruz-Chan, and E. Dumonteil contributed
bystudyconception,design, anddataanalysis;I.A.Quijano-
Hern´ andez, A. Castro-Barcena, E. Aparicio-Burgos, and M.
Barbosa-Mireles by data adquisition, analysis, and interpre-
tation; I. A. Quijano-Hern´ andez, J. V. Cruz-Chan, M. Bolio-
Gonz´ alez, and E. Dumonteil by drafting and revision of the
paper. All authors ﬁnally approved the paper.
Conﬂict of Interests
The authors declare that there is no conﬂict of interests.
Acknowledgments
The authors thank Laucel Ochoa-Garc´ ıa, and personnel at
the Veterinary Teaching Hospital (HVPE-UAEM), for their
invaluable cooperation to assist in the present study. I. A.
Quijano-Hern´ andez was supported by Ph.D. scholarship no.
25368 from the Consejo Nacional de Ciencia y Tecnolog´ ıa,
Faculty of Veterinary Medicine, UADY, M´ erida, M´ exico.
References
[1] P.Guedes,V.Veloso,M.Caliarietal.,“Trypanosomacruzihigh
infectivity in vitro is related to cardiac lesions during long-
term infection in Beagle dogs,” Memorias do Instituto Oswaldo
Cruz, vol. 102, no. 2, pp. 141–147, 2007.
[2] R. G¨ u r t l e r ,R .C h u i t ,M .C ´ ecere, M. Casta˜ n e r a ,J .C o h e n ,a n d
E. Segura, “Household prevalence of seropositivity for Try-
panosoma cruzi in three rural villages in northwest Argentina:
environmental, demographic, and entomologic associations,”
The American Journal of Tropical Medicine and Hygiene, vol.
59, no. 5, pp. 741–749, 1998.
[3] M. De Lana, E. Chiari, and W. Tafuri, “Experimental Chagas’
disease in dogs,” Memorias do Instituto Oswaldo Cruz, vol. 87,
no. 1, pp. 59–71, 1992.
[4] Z.A.Andrade,“ImmunopathologyofChagasdisease,”Memo-
rias do Instituto Oswaldo Cruz, vol. 94, supplement 1, pp. 71–
80, 1999.
[5] R. G¨ u r t l e r ,L .C e b a l l o s ,P .O r d ´ o˜ nez-Krasnowski, L. Lanati,
R. Stariolo, and U. Kitron, “Strong host-feeding preferences
of the vector Triatoma infestans modiﬁed by vector density:
implications for the epidemiology of Chagas disease,” PLoS
Neglected Tropical Diseases, vol. 3, no. 5, Article ID e447, p.
e447, 2009.
[6] M. Carneiro, O. Martins-Filho, A. Reis et al., “Diﬀerential
impact of metacyclic and blood trypomastigotes on parasito-
logical, serological and phenotypic features triggered during
acute Trypanosoma cruzi infection in dogs,” Acta Tropica, vol.
101, no. 2, pp. 120–129, 2007.
[7] E. Machado, A. J. Fernandes, S. Murta et al., “A study of
experimental reinfection by Trypanosoma cruzi in dogs,” The
AmericanJournalofTropicalMedicineandHygiene,vol.65,no.
6, pp. 958–965, 2001.
[ 8 ]S .M o r r i s ,S .B a r r ,L .W e i s s ,H .T a n o w i t z ,M .W i t t n e r ,a n dJ .
Bilezikian, “Myocardial β-adrenergic adenylate cyclase com-
plex in a canine model of chagasic cardiomyopathy,” Circula-
tion Research, vol. 69, no. 1, pp. 185–195, 1991.
[9] C. Marinho, D. Bucci, M. L. Dagli et al., “Pathology aﬀects
diﬀerent organs in two mouse strains chronically infected by
a Trypanosoma cruzi clone: a model for genetic studies of
Chagas’ disease,” Infection and Immunity,v o l .7 2 ,n o .4 ,p p .
2350–2357, 2004.
[10] Z.Brener,“GeneralreviewonTrypanosomacruziclassiﬁcation
and taxonomy,” Revista da Sociedade Brasileira de Medicina
Tropical, vol. 18, supplement 1, pp. 1–8, 1985.
[11] F. Noireau, P. Diosque, and M. Jansen, “Trypanosoma cruzi:
adaptation to its vectors and its hosts,” Veterinary Research,
vol. 40, no. 2, article no. 26, 2009.
[12] R. Manning-Cela, A. Cort´ es, E. Gonz´ alez-Rey, C. V. Wesley,
J. Swindle, and A. Gonz´ alez, “LYT1 protein is required for
eﬃcientinvitroinfectionbyTrypanosomacruzi,” Infection and
Immunity, vol. 69, no. 6, pp. 3916–3923, 2001.
[13] J. Cruz-Chan, M. Bolio-Gonz´ alez, R. Col´ ın-Flores, M.
Ramirez-Sierra, I. Quijano-Hern´ andez, and E. Dumonteil,
“Immunopathology of natural infection with Trypanosoma
cruzi in dogs,” Veterinary Parasitology, vol. 162, no. 1-2, pp.
151–155, 2009.
[14] I. Quijano-Hernandez, M. Bolio-Gonz´ alez, J. Rodr´ ıguez-
B u e n ﬁ l ,M .R a m ´ ırez-Sierra, and E. Dumonteil, “Therapeutic
DNA vaccine against Trypanosoma cruzi infection in dogs: a
pilot clinical trial,” Annals of the New York Academy of Sciences,
vol. 1149, pp. 343–346, 2008.
[15] A. Barbabosa-Pliego, H. M. D´ ıaz-Albiter, L. Ochoa-Garc´ ıa et
al., “Trypanosoma cruzi circulating in the southern region
of the State of Mexico (Zumpahuacan) are pathogenic: a
dog model,” The American Journal of Tropical Medicine and
Hygiene, vol. 81, no. 3, pp. 390–395, 2009.
[16] B. Basso, I. Castro, V. Introini, P. Gil, C. Truyens, and E.
Moretti, “Vaccination with Trypanosoma rangeli reduces the
infectiousness of dogs experimentally infected with T. cruzi,”
Vaccine, vol. 25, no. 19, pp. 3855–3858, 2007.